Pharma News, 2020

Darmstadt, Germany - Merck, a leading science and technology company, signed an agreement to sell its allergy business Allergopharma to Dermapharm Holding SE (“Dermapharm”).

A group of 27 prominent public health scientists from outside China is pushing back against a steady stream of stories and even a scientific paper suggesting a laboratory in Wuhan, China, may be the o...

The US Food and Drug Administration (FDA) has accepted Roche’s supplemental Biologics License Application (sBLA), granting Priority Review for Tecentriq (atezolizumab) for ce...

A deep learning algorithm developed at MIT has discovered new antibiotics that can treat drug-resistant diseases by killing 35 powerful bacteria.

US medical technology provider Medtronic has announced the acquisition of Digital Surgery, a UK-based company specialising in surgical AI and digital education and training.

Dogged for months by concerns over manufacturing, Bluebird Bio's ultra-pricey flagship gene therapy Zynteglo was finally cleared for launch in Germany just weeks ago.

India and the FDA has sometimes had a strained relationship given how often the agency has come down on Indian drugmakers for manufacturing lapses.

Health officials in China have published the first details of more than 44,000 cases of Covid-19, in the biggest study since the outbreak began.

The end is near for a GlaxoSmithKline OTC plant in Pennsylvania and its 260 employees.

Malaria parasites can sense a molecule produced by approaching immune cells and then use it to protect themselves from destruction, according to new findings published today in eLife.

Most people infected by the new coronavirus in China have mild symptoms, with older patients and those with underlying conditions most at risk from the disease, according to a study by Chinese researc...

The top contributor to familial Parkinson's disease is mutations in leucine-rich repeat kinase 2 (LRRK2), whose large and difficult structure has finally been solved, paving the way for ta...